Iranian
Biomedical Journal
Volume 30, Issue 4 (9-2026)
IBJ 2026, 30(4): 262-270 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Marhamati S, Jalili H, Ziamajidi N, Bahmani M, Abbasalipourkabir* R. Integrative Analysis of IGFL2‑AS1 and BRCA1 Expression in Esophageal Cancer: An Experimental and Bioinformatics‑Based Study. IBJ 2026; 30 (4) :262-270
URL: http://ibj.pasteur.ac.ir/article-1-5581-en.html
URL: http://ibj.pasteur.ac.ir/article-1-5581-en.html
Shayan Marhamati 
, Hossein Jalili , Nasrin Ziamajidi , Mahdi Bahmani * , Roghayeh Abbasalipourkabir*
, Hossein Jalili , Nasrin Ziamajidi , Mahdi Bahmani * , Roghayeh Abbasalipourkabir*
Abstract:
Background: Esophageal cancer (EC) is a leading cause of cancer-related death worldwide. The long non-coding RNA IGFL2-AS1 is implicated in malignancies, but its role in EC remains unclear. This study evaluated the expression of IGFL2-AS1 and BRCA1 in EC.
Methods: Sixteen paired EC and adjacent non-tumorous tissues were collected. The expression levels of IGFL2‑AS1 and BRCA1 were quantified using RT‑qPCR, and BRCA1 protein levels were determined using Western blotting. GEPIA, STRING, and g:Profiler were used for bioinformatic analyses. Receiver-operating characteristic (ROC) curves and correlation tests were performed for statistical evaluation.
Results: Both IGFL2-AS1 and BRCA1 were significantly downregulated in EC tissues compared to adjacent normal controls (p < 0.05). A positive correlation was observed between their expression levels. ROC analysis indicated diagnostic potential for both genes (AUC>0.75), with BRCA1 showing superior accuracy. Western blotting confirmed decreased BRCA1 protein levels in tumor samples. Interestingly, GEPIA data suggested an upregulation of both genes in EC. Functional enrichment analysis linked BRCA1-associated genes to ephrin receptor signaling and axon guidance pathways.
Conclusion: Concurrent downregulation of IGFL2‑AS1 and BRCA1 at transcript and protein levels was observed in EC tissues, with a positive correlation between their expression levels. ROC curve analysis suggested their potential as candidate biomarkers. However, these findings are preliminary and require further validation.
Methods: Sixteen paired EC and adjacent non-tumorous tissues were collected. The expression levels of IGFL2‑AS1 and BRCA1 were quantified using RT‑qPCR, and BRCA1 protein levels were determined using Western blotting. GEPIA, STRING, and g:Profiler were used for bioinformatic analyses. Receiver-operating characteristic (ROC) curves and correlation tests were performed for statistical evaluation.
Results: Both IGFL2-AS1 and BRCA1 were significantly downregulated in EC tissues compared to adjacent normal controls (p < 0.05). A positive correlation was observed between their expression levels. ROC analysis indicated diagnostic potential for both genes (AUC>0.75), with BRCA1 showing superior accuracy. Western blotting confirmed decreased BRCA1 protein levels in tumor samples. Interestingly, GEPIA data suggested an upregulation of both genes in EC. Functional enrichment analysis linked BRCA1-associated genes to ephrin receptor signaling and axon guidance pathways.
Conclusion: Concurrent downregulation of IGFL2‑AS1 and BRCA1 at transcript and protein levels was observed in EC tissues, with a positive correlation between their expression levels. ROC curve analysis suggested their potential as candidate biomarkers. However, these findings are preliminary and require further validation.
Type of Study: Short Communication |
Subject:
Cancer Biology
References
1. Marhamati S, Seyedkhan Z, Ziamajidi N, Bahreini F, Emami Razavi A, bahmani M, et al. Integrated Bioinformatic and Experimental Analysis of LINC00472, LINC02381, FHIT, and hsa-miR-7-5p Expression, Alongside FHIT Protein, in Esophageal Cancer. International Journal of Molecular and Cellular Medicine. 2026;15(1):1143-57.
2. Sheikh M, Roshandel G, McCormack V, Malekzadeh R. Current Status and Future Prospects for Esophageal Cancer. Cancers (Basel). 2023;15(3). [DOI:10.3390/cancers15030765]
3. Bahmani M, Kalantary-Charvadeh A, Hamrahjoo M, Ziamajidi N, Abbasalipourkabir R, Marhamati S. Expression patterns, regulatory interactions, and diagnostic potential of LINC00839 and LINC01605 in esophageal cancer. Biochem Biophys Rep. 2025;44:102305. [DOI:10.1016/j.bbrep.2025.102305]
4. Kalantary-Charvadeh A, Morovat S, Aslani S, Ziamajidi N, Emami Razavi A, Abbasalipourkabir R. The role of long non-coding RNA LINC00839 in oral squamous cell carcinoma based on bioinformatics and experimental research. Sci Rep. 2024;14(1):31817. [DOI:10.1038/s41598-024-82922-6]
5. Wang J, Ji W, Qu H, Sun Y, Zhang T. LncRNA ADAMTS9-AS1 regulates the proliferation, migration, and invasion of esophageal cancer cells via miR-575/ CADM2. Discov Oncol. 2025;16(1):1660. [DOI:10.1007/s12672-025-03248-x]
6. Zhao R, Wang S, Tan L, Li H, Liu J, Zhang S. IGFL2-AS1 facilitates tongue squamous cell carcinoma progression via Wnt/β-catenin signaling pathway. Oral Dis. 2023;29(2):469-82. [DOI:10.1111/odi.13935]
7. Lee J, Kim DY, Kim Y, Shin US, Kim KS, Kim EJ. IGFL2-AS1, a Long Non-Coding RNA, Is Associated with Radioresistance in Colorectal Cancer. Int J Mol Sci. 2023;24(2). [DOI:10.3390/ijms24020978]
8. Khalizieva A, Moser SC, Bouwman P, Jonkers J. BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality. Genes Dev. 2025;39(1-2):86-108. [DOI:10.1101/gad.352083.124]
9. Gao Y, Zhu J, Zhang X, Wu Q, Jiang S, Liu Y, et al. BRCA1 mRNA expression as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma treated with cisplatin- or docetaxel-based chemotherapy/chemoradiotherapy. PLoS One. 2013;8(1):e52589. [DOI:10.1371/journal.pone.0052589]
10. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-8. [DOI:10.1006/meth.2001.1262]
11. Yamashita SN, Tanaka Y, Islam S, Kitagawa T, Tokuda K, Paudel D, et al. The UALCAN and GEPIA Analyses of the TCGA Database Show a Strong Association Between Increased Expression of Stathmin 1 in Adrenocortical Carcinoma Tissues and Patient Survival. Anticancer Res. 2025;45(9):3913-20. [DOI:10.21873/anticanres.17749]
12. Marhamati S, Abbasalipourkabir R, Seyedkhan Z, Ziamajidi N, Bahreini F, Razavi AE, et al. Investigating the expression of hsa_circ_0036722/hsa-miR-503-5p/PDCD4 axis in esophageal cancer. Discover Oncology. 2025;17(1):72. [DOI:10.1007/s12672-025-03940-y]
13. Jiang W, Zhang B, Xu J, Xue L, Wang L. Current status and perspectives of esophageal cancer: a comprehensive review. Cancer Commun (Lond). 2025;45(3):281-331. [DOI:10.1002/cac2.12645]
14. Das PK, Islam F, Smith RA, Lam AK. Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas. Front Oncol. 2020;10:598957. [DOI:10.3389/fonc.2020.598957]
15. You M, Xie Z, Zhang N, Zhang Y, Xiao D, Liu S, et al. Signaling pathways in cancer metabolism: mechanisms and therapeutic targets. Signal Transduct Target Ther. 2023;8(1):196. [DOI:10.1038/s41392-023-01442-3]
16. Wei H, Fang R, Zhang S, Lin X, Li L. Current advances in the functional role of long non-coding RNAs in the oncogenesis and metastasis of esophageal squamous cell carcinoma: a narrative review. Transl Cancer Res. 2025;14(3):2150-67. [DOI:10.21037/tcr-24-1048]
17. 17. Qin M, Liu Q, Yang W, Wang Q, Xiang Z. IGFL2-AS1-induced suppression of HIF-1α degradation promotes cell proliferation and invasion in colorectal cancer by upregulating CA9. Cancer Med. 2023;12(7):8415-32. [DOI:10.1002/cam4.5562]
18. Qin H, Xu J, Yue Y, Chen M, Zhang Z, Xu P, et al. Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC. Front Immunol. 2024;15:1456649. [DOI:10.3389/fimmu.2024.1456649]
19. He Y, Rivera J, Diossy M, Duan H, Bowman-Colin C, Reed R, et al. BRCA1/Trp53 heterozygosity and replication stress drive esophageal cancer development in a mouse model. Proc Natl Acad Sci U S A. 2021;118(41). [DOI:10.1073/pnas.2108421118]
20. Starr J, Ramnaraign B. Germline BRCA1 mutated esophageal squamous cell carcinoma. Rare Tumors. 2020;12:2036361320972218. [DOI:10.1177/2036361320972218]
21. Pasquale EB. Eph-ephrin bidirectional signaling in physiology and disease. Cell. 2008;133(1):38-52. [DOI:10.1016/j.cell.2008.03.011]
22. Pasquale EB. Eph receptors and ephrins in cancer progression. Nature Reviews Cancer. 2024;24(1):5-27. [DOI:10.1038/s41568-023-00634-x]
23. Ma Y, Liu Y, Pu YS, Cui ML, Mao ZJ, Li ZZ, et al. LncRNA IGFL2-AS1 functions as a ceRNA in regulating ARPP19 through competitive binding to miR-802 in gastric cancer. Mol Carcinog. 2020;59(3):311-22. [DOI:10.1002/mc.23155]
24. TarBase. TarBase v9 Interactions for hsa-miR-802: TarBase 2025 [Available from: https://dianalab.e-ce.uth.gr/tarbasev9/interactions?gene=&mirna=hsa-miR-802.
25. Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nature Reviews Clinical Oncology. 2018;15(2):81-94. [DOI:10.1038/nrclinonc.2017.166]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |